Ketone monitoring to prevent dangerous acid buildup in type 1 diabetes
Treatments studied
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests different ways to monitor ketones (substances that can build up dangerously when your body lacks insulin) to lower the risk of diabetic ketoacidosis (DKA) in people with type 1 diabetes who also take SGLT-2 inhibitors (a type of diabetes drug). You'll wear a small sensor and follow a meal plan with carbs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have type 1 diabetes.
- Your most recent A1c (a blood test showing average sugar over 3 months) is below 9%.
- You use insulin, either by injections, a pump, or an automated system.
- You are willing to wear a small sensor (investigational device) that monitors ketones in your body.
- You haven't had diabetic ketoacidosis (a dangerous build-up of acids in the blood) in the last 6 months.
- You can eat a diet that includes at least 20% of calories from carbohydrates.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a continuous glucose monitor affects diabetic ketoacidosis (DKA) risk. By tracking glucose levels closely, researchers hope to reduce dangerous complications.
This study looks at how stopping a common diabetes drug (SGLT2 inhibitor) affects the body's risk of a serious condition called ketoacidosis. It may help understand who is most at risk and how to prevent it.
This trial tests how combining a ketone supplement with certain diabetes medicines affects blood sugar and ketone levels. It may help adults with type 2 diabetes who are not on insulin or certain other drugs.
This study compares two ways of tracking blood sugar in people with type 2 diabetes who use insulin. It aims to see if one method helps manage glucose better, which could improve daily control and long-term health.
This study tests whether using a dual continuous glucose and ketone monitor can help people with type 1 diabetes safely take a class of drugs called SGLT2 inhibitors, which may improve blood sugar control but can increase the risk of diabetic ketoacidosis (DKA). By closely monitoring changes in glucose and ketone levels, the study aims to prevent dangerous episodes while benefiting from the drug's effects.
This study is testing a new wearable sensor that tracks both glucose (sugar) and ketone levels continuously. It might help people with type 1 diabetes manage their condition better and avoid complications.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.